Navigation Links
ViroPharma Incorporated Reports Second Quarter 2009 Financial Results
Date:7/29/2009

data) June 30, June 30, -------- -------- 2009 2008* 2009 2008* ---- ---- ---- ---- (unaudited) (unaudited) Revenues: Net product sales $81,873 $65,437 $142,063 $116,374 Costs and Expenses: Cost of sales (excluding amortization of product rights) 14,121 2,386 18,049 4,304 Research and development 12,467 14,584 32,151 28,999 Selling, general and administrative 23,612 16,605 47,990 30,004 Intangible amortization 7,424 2,145 14,681 3,833 Goodwill impairment - - 65,099 - --- --- ------ --- Total costs and expenses 57,624 35,720 177,970 67,140 ------ ------ ------- ------ Operating income (loss) 24,249 29,717 (35,907) 49,234 Interest income 105 4,067 250 10,378 Interest expense (2,677) (3,218) (5,986) (6,346) Gain on senior convertible note repurchase - - 9,079 - --- --- ----- --- Income (loss) before income tax expense 21,677 30,566 (32,564) 53,266 Income tax expense 5,625 7,783 10,599 14,098 ----- ----- ------ ------ Net income (loss) $16,052 $22,783 $(43,163) $39,168 ======= =======
'/>"/>
SOURCE ViroPharma Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine news :

1. ViroPharma to Release 2009 Second Quarter Financial Results on July 29, 2009
2. ViroPharma Announces Appointment of Frank Baldino, Jr., Ph.D. to Board of Directors
3. ViroPharma Announces Meeting of FDA Advisory Committee for Pharmaceutical Science and Clinical Pharmacology on Bioequivalence Recommendations for Oral Vancomycin Hydrochloride Products
4. ViroPharma to Present at Two May Healthcare Conferences
5. ViroPharma to Present at the Cowen & Company 29th Annual Healthcare Conference
6. ViroPharma to Host Investor Teach-In Educational Symposium on Hereditary Angioedema
7. ViroPharma to Release 2008 Fourth Quarter and Full Year Financial Results on February 24, 2009
8. ViroPharma Reports Results of Phase 3 Clinical Trial for Maribavir in Bone Marrow Transplant Patients
9. ViroPharma to Present at the 27th Annual J.P. Morgan Healthcare Conference
10. ViroPharma Provides Update on Vancocin(R)
11. ViroPharma Submits Supplemental Biologics License Application for Cinryze(TM) to Treat Acute Attacks of Hereditary Angioedema
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... ... September 02, 2015 , ... A ... partnership has earned international recognition as a premier center for treatment of and ... sudden, catastrophic internal bleeding and stroke. , Cure HHT, previously known as ...
(Date:9/2/2015)... ... September 02, 2015 , ... Since 2011, DoMyOwnPestControl.com ... Atlanta to help support childhood cancer research. On June 17, 2014, the ... Care-A-Thon , which is the fund-raising event DoMyOwnPestControl.com sponsors each year. The very ...
(Date:9/2/2015)... ... September 02, 2015 , ... A ... is taking action after seeing a significant increase in unlawful tactics used by ... has found many cases of OON ASCs encouraging members to have elective procedures ...
(Date:9/2/2015)... Florida (PRWEB) , ... September 02, 2015 , ... A ... drug prices over the past year and its negative impact on consumers. It was ... prescription medication and 10% were paying as much as an extra $100 compared to ...
(Date:9/2/2015)... ... September 02, 2015 , ... SonicSurg Innovations, ... surgical market, announced today that more than 600 successful patient procedures have been ... Plus, nearly 70 of these procedures have been on triggering thumbs. ...
Breaking Medicine News(10 mins):Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 2Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 3Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 4Health News:DoMyOwnPestControl.com Goes Gold for Childhood Cancer Awareness Month 2Health News:TPA Cracks Down on Forbidden Tactics Used by Out-of-Network Surgical Centers 2Health News:TPA Cracks Down on Forbidden Tactics Used by Out-of-Network Surgical Centers 3Health News:Watertree Health President Responds to Consumer Reports Survey on Rising Prescription Drug Prices 2Health News:Trigger Tome Surpasses 600 Successful Patient Procedures 2
... grow old in good health should have strong grip, not ... recent study.// ,A 40-year study of nearly 6000 ... nine factors that were good predictors of which middle-aged men ... ,The nine factors were: not being overweight, low blood sugar ...
... disease in a whole new way, an experimental ... (ITP) once again// produce healthy amounts of platelets ... ,That's the conclusion of a new, multicenter study ... pediatrics at Weill Cornell Medical College, attending pediatrician ...
... progeny are dependant on a fairly simple factor - ... to impact the genes of the future generation//. In ... mice were seen to impact generation of offsprings. The ... of Sciences., ,To quote the researchers,” Although researchers ...
... project which aims at early detection of Alzheimer's and ... //Flagship, a CSIRO program of health research, in Australia. ... Alzheimer's disease, which currently affects 150,000 Australians. ... Emission Tomography (PET scans) on 1000 volunteers from Victoria ...
... of colorectal cancer screening appears to be increasing among ... common than other screening procedures// , according to a ... that younger veterans with other illnesses and reduced life ... may even be harmed, but continue to be screened ...
... up with incriminating evidence that warns non-vegetarians who binge on ... pointed out that eating more than one and a half ... related breast cancer and another study that vitamin supplements ... heart diseases except for vitamin C which seems to show ...
Cached Medicine News:Health News:Keys to Good Health in Old Age Begins in Midlife 2Health News:Drug Boosts Platelet Production, Reversing Immune Thrombocytopenic Purpura 2Health News:Drug Boosts Platelet Production, Reversing Immune Thrombocytopenic Purpura 3Health News:Studies Examine Colorectal Cancer Screening Rates 2Health News:Studies Examine Colorectal Cancer Screening Rates 3Health News:Studies Examine Colorectal Cancer Screening Rates 4Health News:Red alert to women against red meat consumption 2
(Date:9/2/2015)... Physicians Rx Pharmacy ("PRxP") today announced that ... President and Chief Executive Officer.  Mr. Bernstein, ... Officer for Soleo Health Specialty Infusion Services, will, as ... be responsible for leading the rapidly-growing 340B pharmacy services ... Gaston on as the President and CEO of PRxP," ...
(Date:9/2/2015)... Research and Markets ( http://www.researchandmarkets.com/research/275q7t/inhaled_drug ) has ... (London, UK - November 19-20, 2015)" conference to ... will cover industry case studies, regulatory updates, latest therapies ... Dr Steven Nichols , OINP Specialist Consultant and ... Companies participating include: - Aptar ...
(Date:9/2/2015)... Research and Markets ( http://www.researchandmarkets.com/research/hcb7bz/pharmaceutical ) has announced the addition of ... 16-18, 2015)" conference to their offering. Regulatory requirements for ... Peru , Brazil , ... , Paraguay , Venezuela , ... Chile This seminar can be viewed both as ...
Breaking Medicine Technology:Gaston L. Bernstein Named President and CEO of Physicians Rx Pharmacy 2Pharmaceutical Regulatory Affairs in Latin America Seminar - London, UK - November 16-18, 2015 2
... , , , ... to get all their flu shots as soon as the vaccines ... flu and the H1N1 (swine) flu, according to eight leading national ... eight organizations - the March of Dimes, the American College of ...
... , , , ... FRANCISCO, Sept. 23 Late-breaking data from the SPIRIT IV trial ... achieved superiority in the key safety and efficacy measures of target ... TAXUS(R) Express2(TM) Paclitaxel-Eluting Coronary Stent System (TAXUS) at one year. With ...
Cached Medicine Technology:Pregnant Women Need Flu Shots 2Abbott's XIENCE V(R) Superior to TAXUS(R) in Key Safety and Efficacy Measures in SPIRIT IV Trial 2Abbott's XIENCE V(R) Superior to TAXUS(R) in Key Safety and Efficacy Measures in SPIRIT IV Trial 3Abbott's XIENCE V(R) Superior to TAXUS(R) in Key Safety and Efficacy Measures in SPIRIT IV Trial 4Abbott's XIENCE V(R) Superior to TAXUS(R) in Key Safety and Efficacy Measures in SPIRIT IV Trial 5Abbott's XIENCE V(R) Superior to TAXUS(R) in Key Safety and Efficacy Measures in SPIRIT IV Trial 6
Manual Lensmeter....
The Marco Lensmeter 201 features internal readings for the presbyopic practitioner or those who prefer to work in subdued lighting where external readings are difficult....
... million pixel image provides excellent ... for all types of diagnostic ... glaucoma to diabetic retinopathy evaluation. ... filmless, instant review, digital filing ...
Manual lensmeter with AO target, high and wide field eyepiece and better marking dots....
Medicine Products: